Hello there !
I am no expert on these matters but I have a feeling that SHBG levels are
more significant than is generally recognised.
For example here is a snippet:
Arch Gynecol Obstet. 2003 Jun;268(2):107-12. Epub 2002 Sep 26.
The comparison of clinical and hormonal parameters in PCOS patients treated
with
metformin and GnRH analogue.
Cicek MN, Bala A, Celik C, Akyurek C.
Faculty of Medicine, Department of Obstetrics and Gynecology, Selcuk
University,
Akyokus 42080 Konya, Turkey.
... Metformin treatment resulted in a significant decline in mean body mass
index, body weight, circumferences of waist and hip and total hirsutismus
score. There was a significant decrease in luteinizing hormone (LH) levels
and a significant increase in follicle stimulating hormone (FSH),
progesterone, and sex hormone binding globulin (SHBG) concentrations...
Thus although SHBG increased and 'hirsutismus score' improved, it appears
(because it is not mentioned) that there was no significant change in
testosterone/'random number'.
Does anybody think that hirsutism/acne/PCOS etc. may be more clearly related
to SHBG than to testosterone/DHAS/androstenedione etc. ?
Dr Robin Marks
Consultant Chemical Pathologist
Calderdale Royal Hospital
Halifax
HX3 0PW
UK
> -----Original Message-----
> From: JG MIDDLE [mailto:[log in to unmask]]
> Sent: 28 July 2003 14:10
> To: [log in to unmask]
> Subject: Testosterone assays better than guessing?
>
>
> Listmembers who have agonised over which testosterone assay
> to use in women should be aware that a random number
> generator may be just as useful!
>
> The latest edition of Clinical Chemistry includes an article
> describing a major comparison study of commercial
> immunoassays with ID-GCMS (the reference method), and an
> Editorial deploring the current state-of-the-art of
> testosterone assays.
>
> Go here for links
> http://www.ukneqas.org.uk/saf01.htm
>
> To those who have followed the UK NEQAS ID-GCMS exercises
> over the years (you can download a pdf of the latest one for
> testosterone from the SAF link), these findings will come as
> no surprise.
>
> A major collaborative effort between laboratory, clinical and
> industry personnel is needed to address this issue.
>
> Useful discussions were had at the UK NEQAS SAF meeting last
> December; more concerted action is needed now.
>
> Jonathan Middle
>
>
>
> UK NEQAS Birmingham
> tel 0121 414 7300, fax 0121 414 1179
> This message is intended only for the above named
> recipient(s). Message content may be confidential and
> privileged. If it comes to you in error please inform the
> sender and delete it from your system.
> The opinions expressed are mine alone and do not necessarily
> represent those of UK NEQAS Birmingham, the UK NEQAS
> Organisation, the University Hospital Birmingham NHS Trust or
> University of Birmingham.
>
> ------ACB discussion List Information--------
> This is an open discussion list for the academic and clinical
> community working in clinical biochemistry.
> Please note, archived messages are public and can be viewed
> via the internet. Views expressed are those of the individual and
> they are responsible for all message content.
>
> ACB Web Site
> http://www.acb.org.uk
> List Archives
> http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
> List Instructions (How to leave etc.)
> http://www.jiscmail.ac.uk/
>
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|